Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other Non-Current Liabilities (2016 - 2026)

Integra Lifesciences Holdings' Other Non-Current Liabilities history spans 17 years, with the latest figure at $204.3 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 39.69% to $204.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $204.3 million, a 39.69% increase, with the full-year FY2025 number at $204.3 million, up 39.69% from a year prior.
  • Other Non-Current Liabilities hit $204.3 million in Q4 2025 for Integra Lifesciences Holdings, down from $233.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for IART hit a ceiling of $253.2 million in Q2 2025 and a floor of $32.6 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $148.0 million across 5 years, with a median of $149.8 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 72.89% in 2022 and later soared 513.31% in 2023.
  • Tracing IART's Other Non-Current Liabilities over 5 years: stood at $120.3 million in 2021, then plummeted by 72.89% to $32.6 million in 2022, then soared by 513.31% to $199.9 million in 2023, then dropped by 26.86% to $146.2 million in 2024, then soared by 39.69% to $204.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for IART at $204.3 million in Q4 2025, $233.3 million in Q3 2025, and $253.2 million in Q2 2025.